About Consano Bio
Consano Bio is a private company based in Burlington, Massachusetts, incorporated in 2024 in Delaware. It has reported $59,564,466 raised in three offerings on Form D since June 2023. Its chief executive is Andrew Hall.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 6, 2026 | Mar 20, 2026 | $34,824,466of $48.8M target | 28 | $1.2M | EquityRule 506(b) | Form D ↗ |
| Oct 15, 2024 | Dec 12, 2025 | $16,840,000fully sold | 18 | $935K | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| Jun 13, 2023 | Jun 13, 2023 | $7,900,000of $12.0M target | 1 | $7.9M | DebtRule 506(b) | Form D ↗ |
| Total, three offerings | $59,564,466 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Consano Bio's Form D filed Mar 20, 2026.
MP
Michael Pede
Director
BA
Bill Abbington
Director
JC
John Conway
Director
JS
Joe Schiesl
Director
CC
Christopher Centeno
Director
DW
Doug Weide
Director
JA
Jerome Adams
Director
Earlier filings also listed Wayne Schellhammer (interim ceo and director, last listed Jun 2023), Daniel Haders (director, last listed Jun 2023) and Clayton Hartman (director, last listed Jun 2023).
Sources
- SECConsano Bio, Inc. filing history
- CompanyPrivacy policy
- CompanyAbout Consano Bio